IFG Advisory’s Quest Diagnostics DGX Stock Holding History

IFG Advisory’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,301	Closed	-$314K	–	479
2022 Q1	$314K	Sell	2,301 -852	-27%	-$119K	0.03%	388
2021 Q4	$545K	Hold	3,153	–	–	0.05%	283
2021 Q3	$458K	Sell	3,153 -24	-0.8%	-$3.51K	0.05%	312
2021 Q2	$419K	Sell	3,177 -807	-20%	-$106K	0.05%	328
2021 Q1	$511K	Buy	3,984 +1,815	+84%	+$224K	0.06%	296
2020 Q4	$258K	Hold	2,169	–	–	0.04%	381
2020 Q3	$248K	Hold	2,169	–	–	0.04%	358
2020 Q2	$247K	Buy	+2,169	New	+$230K	0.04%	341
2020 Q1	–	Sell	-2,316	Closed	-$247K	–	374
2019 Q4	$247K	Hold	2,316	–	–	0.05%	352
2019 Q3	$247K	Sell	2,316 -1,917	-45%	-$197K	0.05%	339
2019 Q2	$430K	Buy	4,233 +105	+3%	+$10.1K	0.08%	221
2019 Q1	$371K	Buy	4,128 +274	+7%	+$23.7K	0.07%	233
2018 Q4	$320K	Sell	3,854 -404	-9%	-$37.9K	0.08%	236
2018 Q3	$459K	Sell	4,258 -535	-11%	-$58.7K	0.09%	225
2018 Q2	$526K	Buy	4,793 +218	+5%	+$22.7K	0.11%	183
2018 Q1	$458K	Sell	4,575 -864	-16%	-$88.5K	0.1%	194
2017 Q4	$535K	Buy	+5,439	New	+$516K	0.12%	166

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

IFG Advisory's DGX Position: Q2 2022 in Review

IFG Advisory sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 2,301 shares — an estimated $314K sold.

IFG Advisory first reported a position in DGX in Q4 2017 and held it in 17 quarters. The position peaked at $545K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

IFG Advisory reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
IFG Advisory sold 2,301 Quest Diagnostics shares in Q2 2022, an estimated $314K.
IFG Advisory first reported a position in Quest Diagnostics in Q4 2017 and held it in 17 quarters.
IFG Advisory's Quest Diagnostics position peaked at $545K in Q4 2021.
851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on IFG Advisory's 13F filing for Q2 2022, filed 4 Aug 2022.